Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2013

01.06.2013 | Original Paper

Increase of N 1 ,N 12-diacetylspermine in tissues from colorectal cancer and its liver metastasis

verfasst von: Go Kuwata, Kyoko Hiramatsu, Keijiro Samejima, Kaori Iwasaki, Kei-ichi Takahashi, Koichi Koizumi, Shin-ichiro Horiguchi, Shun-suke Moriya, Masaki Kobayashi, Masao Kawakita

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

N 1 ,N 12-Diacetylspermine (DiAcSpm) is a tumor marker featured by increase in the urine of patients with cancers, including early colorectal cancer, but where and how DiAcSpm is made remains unclear. We aimed to clarify whether colorectal cancer tissues produce increased amounts of DiAcSpm, and if they do, to examine whether tissue DiAcSpm level may serve as a criterion of tissue malignancy.

Methods

Tissue samples were obtained from 140 patients (13 low-grade intraepithelial neoplasia, 98 high-grade intraepithelial neoplasia and 29 colorectal cancer) treated for colorectal cancer and intraepithelial neoplasia at Tokyo Metropolitan Komagome Hospital between November 2007 and April 2011. The DiAcSpm level in cancer and adjacent normal tissue extracts was compared, and its relationship with clinical stages of the diseases was analyzed.

Results

DiAcSpm levels were higher in colorectal cancer tissue (p < 0.01, n = 12) and its liver metastasis (p < 0.05, n = 5) than in adjacent normal tissues. The tumor/normal ratio of tissue DiAcSpm content was examined for endoscopically obtained tumor and adjacent normal tissues from patients with intraepithelial neoplasia. The ratio was greater than 1.5 in 38 % (5/13) and 78 % (84/108) of low-grade intraepithelial neoplasia and high-grade intraepithelial neoplasia, respectively.

Conclusions

Tissue DiAcSpm levels increase in the tissue of colorectal cancer and also in precancerous lesion, such as high-grade intraepithelial neoplasia. The increase is considered a sign that a tissue is acquiring malignant characteristics. It is likely that the DiAcSpm produced by cancer cells is responsible for the frequent increase in urinary DiAcSpm in early cancer patients.
Literatur
Zurück zum Zitat Hamaoki M, Nagata A (2006) Host macrophages produce diacetylspermine related with tumorigenesis. Cancer Lett 243:128–134PubMedCrossRef Hamaoki M, Nagata A (2006) Host macrophages produce diacetylspermine related with tumorigenesis. Cancer Lett 243:128–134PubMedCrossRef
Zurück zum Zitat Hiramatsu K, Kamei S, Sugimoto M, Kinoshita K, Iwasaki K, Kawakita M (1994) An improved method of determining free and acetylated polyamines by HPLC involving an enzyme reactor and an electrochemical detector. J Biochem 115:584–589PubMed Hiramatsu K, Kamei S, Sugimoto M, Kinoshita K, Iwasaki K, Kawakita M (1994) An improved method of determining free and acetylated polyamines by HPLC involving an enzyme reactor and an electrochemical detector. J Biochem 115:584–589PubMed
Zurück zum Zitat Hiramatsu K, Sugimoto M, Kamei S, Hoshino M, Kinoshita K, Iwasaki K, Kawakita M (1995) Determination of amounts of polyamines excreted in urine: demonstration of N 1, N 8-diacetylspermidine and N 1,N 12-diacetylspermine as components commonly occurring in normal human urine. J Biochem 117:107–112PubMed Hiramatsu K, Sugimoto M, Kamei S, Hoshino M, Kinoshita K, Iwasaki K, Kawakita M (1995) Determination of amounts of polyamines excreted in urine: demonstration of N 1, N 8-diacetylspermidine and N 1,N 12-diacetylspermine as components commonly occurring in normal human urine. J Biochem 117:107–112PubMed
Zurück zum Zitat Hiramatsu K, Sugimoto M, Kamei S, Hoshino M, Kinoshita K, Iwasaki K, Kawakita M (1997) Diagnostic and prognostic usefulness of N 1, N 8-diacetylspermidine and N 1,N 12-diacetylspermine in urine as novel markers of malignancy. J Cancer Res Clin Oncol 123:539–545PubMedCrossRef Hiramatsu K, Sugimoto M, Kamei S, Hoshino M, Kinoshita K, Iwasaki K, Kawakita M (1997) Diagnostic and prognostic usefulness of N 1, N 8-diacetylspermidine and N 1,N 12-diacetylspermine in urine as novel markers of malignancy. J Cancer Res Clin Oncol 123:539–545PubMedCrossRef
Zurück zum Zitat Hiramatsu K, Takahashi K, Yamaguchi T, Matsumoto H, Miyamoto H, Tanaka S, Tanaka C, Tamamori Y, Imajo M, Kawaguchi M, Toi M, Mori T, Kawakita M (2005) N 1,N 12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. Clin Cancer Res 11:2986–2990PubMedCrossRef Hiramatsu K, Takahashi K, Yamaguchi T, Matsumoto H, Miyamoto H, Tanaka S, Tanaka C, Tamamori Y, Imajo M, Kawaguchi M, Toi M, Mori T, Kawakita M (2005) N 1,N 12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. Clin Cancer Res 11:2986–2990PubMedCrossRef
Zurück zum Zitat Kawakita M, Hiramatsu K (2006) Diacetylated derivatives of spermine and spermidine as novel promising tumor markers. J Biochem 139:315–322PubMedCrossRef Kawakita M, Hiramatsu K (2006) Diacetylated derivatives of spermine and spermidine as novel promising tumor markers. J Biochem 139:315–322PubMedCrossRef
Zurück zum Zitat Kawakita M, Hiramatsu K, Yanagiya M, Doi Y, Kosaka M (2011) Determination of N 1,N 12-diacetylspermine in urine: a novel tumor marker. In: Pegg AE, Casero RA (eds) Methods in molecular biology vol. 720. Humana Press, New York, pp 367–378 Kawakita M, Hiramatsu K, Yanagiya M, Doi Y, Kosaka M (2011) Determination of N 1,N 12-diacetylspermine in urine: a novel tumor marker. In: Pegg AE, Casero RA (eds) Methods in molecular biology vol. 720. Humana Press, New York, pp 367–378
Zurück zum Zitat Kingsnorth AN, Wallace HM (1985) Elevation of monoacetylated polyamines in human breast cancers. Eur J Cancer Clin Oncol 21:1057–1062PubMedCrossRef Kingsnorth AN, Wallace HM (1985) Elevation of monoacetylated polyamines in human breast cancers. Eur J Cancer Clin Oncol 21:1057–1062PubMedCrossRef
Zurück zum Zitat Kobayashi M, Samejima K, Hiramatsu K, Kawakita M (2002) Mass spectrometric separation and determination of N 1,N 12-diacetylspermine in the urine of cancer patients. Biol Pharm Bull 25:372–374PubMedCrossRef Kobayashi M, Samejima K, Hiramatsu K, Kawakita M (2002) Mass spectrometric separation and determination of N 1,N 12-diacetylspermine in the urine of cancer patients. Biol Pharm Bull 25:372–374PubMedCrossRef
Zurück zum Zitat Miki T, Hiramatsu K, Kawakita M (2005) Interaction of N 1,N 12-diacetylspermine with polyamine transport systems of polarized porcine renal cell line LLC-PK1. J Biochem 138:479–484PubMedCrossRef Miki T, Hiramatsu K, Kawakita M (2005) Interaction of N 1,N 12-diacetylspermine with polyamine transport systems of polarized porcine renal cell line LLC-PK1. J Biochem 138:479–484PubMedCrossRef
Zurück zum Zitat Samejima K, Otani M, Murakami Y, Oka T, Kasai M, Tsumoto H, Kohda K (2007) Electrospray ionization and time-of-flight mass spectrometric method for simultaneous determination of spermidine and spermine. Biol Pharm Bull 30:1943–1946PubMedCrossRef Samejima K, Otani M, Murakami Y, Oka T, Kasai M, Tsumoto H, Kohda K (2007) Electrospray ionization and time-of-flight mass spectrometric method for simultaneous determination of spermidine and spermine. Biol Pharm Bull 30:1943–1946PubMedCrossRef
Zurück zum Zitat Samejima K, Hiramatsu K, Takahashi K, Kawakita M, Kobayashi M, Tsumoto H, Kohda K (2010) Identification and determination of urinary acetylpolyamines in cancer patients by electrospray ionization and time-of-flight mass spectrometry. Anal Biochem 401:22–29PubMedCrossRef Samejima K, Hiramatsu K, Takahashi K, Kawakita M, Kobayashi M, Tsumoto H, Kohda K (2010) Identification and determination of urinary acetylpolyamines in cancer patients by electrospray ionization and time-of-flight mass spectrometry. Anal Biochem 401:22–29PubMedCrossRef
Zurück zum Zitat Sugimoto M, Hiramatsu K, Kamei S, Kinoshita K, Hoshino M, Iwasaki K, Kawakita M (1995) Significance of urinary N1, N8-diacetylspermidine and N 1,N 12-diacetylspermine as indicators of neoplastic diseases. J Cancer Res Clin Oncol 121:317–319PubMedCrossRef Sugimoto M, Hiramatsu K, Kamei S, Kinoshita K, Hoshino M, Iwasaki K, Kawakita M (1995) Significance of urinary N1, N8-diacetylspermidine and N 1,N 12-diacetylspermine as indicators of neoplastic diseases. J Cancer Res Clin Oncol 121:317–319PubMedCrossRef
Zurück zum Zitat Takenoshita S, Matsuzaki S, Nakano G-I, Kimura H, Hoshi H, Shoda H, Nakamura T (1984) Selective elevation of the N 1-acetylspermidine level in human colorectal adenocarcinomas. Cancer Res 44:845–847PubMed Takenoshita S, Matsuzaki S, Nakano G-I, Kimura H, Hoshi H, Shoda H, Nakamura T (1984) Selective elevation of the N 1-acetylspermidine level in human colorectal adenocarcinomas. Cancer Res 44:845–847PubMed
Zurück zum Zitat Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, Porter CW (2000) Effects of conditional overexpression of spermidine/spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 275:38319–38328PubMedCrossRef Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, Porter CW (2000) Effects of conditional overexpression of spermidine/spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 275:38319–38328PubMedCrossRef
Zurück zum Zitat Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 6:3657–3661PubMed Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 6:3657–3661PubMed
Metadaten
Titel
Increase of N 1 ,N 12-diacetylspermine in tissues from colorectal cancer and its liver metastasis
verfasst von
Go Kuwata
Kyoko Hiramatsu
Keijiro Samejima
Kaori Iwasaki
Kei-ichi Takahashi
Koichi Koizumi
Shin-ichiro Horiguchi
Shun-suke Moriya
Masaki Kobayashi
Masao Kawakita
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2013
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-013-1405-5

Weitere Artikel der Ausgabe 6/2013

Journal of Cancer Research and Clinical Oncology 6/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.